118 related articles for article (PubMed ID: 21512047)
1. Volumetric arterial enhancement fraction predicts tumor recurrence after hepatic radiofrequency ablation of liver metastases: initial results.
Mahnken AH; Klotz E; Schreiber S; Bruners P; Isfort P; Günther RW; Wildberger JE
AJR Am J Roentgenol; 2011 May; 196(5):W573-9. PubMed ID: 21512047
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival.
Mazzaglia PJ; Berber E; Milas M; Siperstein AE
Surgery; 2007 Jul; 142(1):10-9. PubMed ID: 17629995
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
Kawamura Y; Ikeda K; Seko Y; Hosaka T; Kobayashi M; Saitoh S; Kumada H
AJR Am J Roentgenol; 2011 Oct; 197(4):W665-73. PubMed ID: 21940538
[TBL] [Abstract][Full Text] [Related]
5. Detection of recurrent hepatocellular carcinoma in cirrhotic liver after transcatheter arterial chemoembolization: value of quantitative color mapping of the arterial enhancement fraction of the liver.
Lee DH; Lee JM; Klotz E; Kim SJ; Kim KW; Han JK; Choi BI
Korean J Radiol; 2013; 14(1):51-60. PubMed ID: 23323031
[TBL] [Abstract][Full Text] [Related]
6. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
[TBL] [Abstract][Full Text] [Related]
7. Early detection of local RFA site recurrence using total liver volume perfusion CT initial experience.
Meijerink MR; van Waesberghe JH; van der Weide L; van den Tol P; Meijer S; Comans EF; Golding RP; van Kuijk C
Acad Radiol; 2009 Oct; 16(10):1215-22. PubMed ID: 19524457
[TBL] [Abstract][Full Text] [Related]
8. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT.
Chopra S; Dodd GD; Chintapalli KN; Leyendecker JR; Karahan OI; Rhim H
AJR Am J Roentgenol; 2001 Aug; 177(2):381-7. PubMed ID: 11461868
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases.
Schraml C; Clasen S; Schwenzer NF; Koenigsrainer I; Herberts T; Claussen CD; Pereira PL
Abdom Imaging; 2008; 33(6):643-51. PubMed ID: 18175165
[TBL] [Abstract][Full Text] [Related]
10. [Radiofrequency ablation of malignant liver tumors: use of a volumetric necrosis-tumor ratio for local control].
Kühl H; Stattaus J; Kühl B; Boes T; Antoch G; Frilling A; Forsting M
Rofo; 2006 Dec; 178(12):1243-9. PubMed ID: 17136648
[TBL] [Abstract][Full Text] [Related]
11. Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma.
Kim KW; Lee JM; Klotz E; Park HS; Lee DH; Kim JY; Kim SJ; Kim SH; Lee JY; Han JK; Choi BI
Radiology; 2009 Feb; 250(2):425-434. PubMed ID: 19188314
[TBL] [Abstract][Full Text] [Related]
12. Semiautomated versus manual evaluation of liver metastases treated by radiofrequency ablation.
Keil S; Bruners P; Ohnsorge L; Plumhans C; Behrendt FF; Stanzel S; Sühling M; Günther RW; Das M; Mahnken AH
J Vasc Interv Radiol; 2010 Feb; 21(2):245-51. PubMed ID: 20123208
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
Mikami S; Tateishi R; Akahane M; Asaoka Y; Kondo Y; Goto T; Shiina S; Yoshida H; Koike K
J Vasc Interv Radiol; 2012 Oct; 23(10):1269-75. PubMed ID: 22999746
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency Ablation of Hepatic Tumor: Subjective Assessment of the Perilesional Vascular Network on Contrast-Enhanced Computed Tomography Before and After Ablation Can Reliably Predict the Risk of Local Recurrence.
Yedururi S; Terpenning S; Gupta S; Fox P; Martin SS; Conrad C; Loyer EM
J Comput Assist Tomogr; 2017; 41(4):607-613. PubMed ID: 28722702
[TBL] [Abstract][Full Text] [Related]
15. Dual-energy CT in assessing therapeutic response to radiofrequency ablation of renal cell carcinomas.
Park SY; Kim CK; Park BK
Eur J Radiol; 2014 Feb; 83(2):e73-9. PubMed ID: 24345460
[TBL] [Abstract][Full Text] [Related]
16. Liver metastases on quantitative color mapping of the arterial enhancement fraction from multiphasic CT scans: evaluation of the hemodynamic features and correlation with the chemotherapy response.
Joo I; Lee JM; Kim KW; Klotz E; Han JK; Choi BI
Eur J Radiol; 2011 Dec; 80(3):e278-83. PubMed ID: 21251785
[TBL] [Abstract][Full Text] [Related]
17. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.
Donckier V; Van Laethem JL; Goldman S; Van Gansbeke D; Feron P; Ickx B; Wikler D; Gelin M
J Surg Oncol; 2003 Dec; 84(4):215-23. PubMed ID: 14756432
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment microbubble-induced enhancement in hepatocellular carcinoma predicts intrahepatic distant recurrence after radiofrequency ablation.
Maruyama H; Takahashi M; Shimada T; Sekimoto T; Kamesaki H; Kanai F; Yokosuka O
AJR Am J Roentgenol; 2013 Mar; 200(3):570-7. PubMed ID: 23436846
[TBL] [Abstract][Full Text] [Related]
19. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.
Langenhoff BS; Oyen WJ; Jager GJ; Strijk SP; Wobbes T; Corstens FH; Ruers TJ
J Clin Oncol; 2002 Nov; 20(22):4453-8. PubMed ID: 12431968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
